| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.11e-07 | 26 | 184 | 6 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.18e-07 | 14 | 184 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-dependent protein kinase activity | 8.48e-07 | 9 | 184 | 4 | GO:0004690 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.54e-06 | 26 | 184 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 2.62e-05 | 7 | 184 | 3 | GO:0004691 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | EEFSEC EFL1 SMARCA5 ABCA2 SMCHD1 APTX DNAH2 PSMC5 SMARCAD1 RRAS SMC2 ABCA9 DNAH12 ARL13B RASL11B TOR1B GNAS DNAH5 YME1L1 RAB27A SMC1B | 3.24e-05 | 839 | 184 | 21 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | EEFSEC EFL1 SMARCA5 ABCA2 SMCHD1 APTX DNAH2 PSMC5 SMARCAD1 RRAS SMC2 ABCA9 DNAH12 ARL13B RASL11B TOR1B GNAS DNAH5 YME1L1 RAB27A SMC1B | 3.30e-05 | 840 | 184 | 21 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | EEFSEC EFL1 SMARCA5 ABCA2 SMCHD1 APTX DNAH2 PSMC5 SMARCAD1 RRAS SMC2 ABCA9 DNAH12 ARL13B RASL11B TOR1B GNAS DNAH5 YME1L1 RAB27A SMC1B | 3.30e-05 | 840 | 184 | 21 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | EEFSEC EFL1 SMARCA5 ABCA2 SMCHD1 DNAH2 PSMC5 SMARCAD1 RRAS SMC2 ABCA9 DNAH12 ARL13B RASL11B TOR1B GNAS DNAH5 YME1L1 RAB27A SMC1B | 3.30e-05 | 775 | 184 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 3.69e-05 | 21 | 184 | 4 | GO:0019200 | |
| GeneOntologyMolecularFunction | fructose transmembrane transporter activity | 6.21e-05 | 9 | 184 | 3 | GO:0005353 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 6.35e-05 | 46 | 184 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 8.81e-05 | 10 | 184 | 3 | GO:0004679 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.15e-04 | 52 | 184 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PRPSAP2 HK1 HK2 MARK1 RPS6KB1 POLR2A IRAK2 MAGI3 CAMK1G PIGG PFKFB2 PFKL MLKL MET MTOR EPHA2 PRKACA PRKACB PRKAG1 PRKG2 EPHA7 | 1.57e-04 | 938 | 184 | 21 | GO:0016772 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | SMARCA5 ABCA2 SMCHD1 DNAH2 PSMC5 SMARCAD1 SMC2 ABCA9 DNAH12 TOR1B DNAH5 YME1L1 SMC1B | 2.36e-04 | 441 | 184 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | kinase binding | ATG13 POLR2A PIWIL1 GRIA1 TWF2 TDG PFKFB2 PFKL STAT3 MLKL MTOR FZD5 SCN5A PRKACA PRKAG1 C1QBP PRKN PLCB4 DUSP10 PRKG2 CDC25B | 2.44e-04 | 969 | 184 | 21 | GO:0019900 |
| GeneOntologyMolecularFunction | kinase activity | HK1 HK2 MARK1 RPS6KB1 IRAK2 MAGI3 CAMK1G PFKFB2 PFKL MLKL MET MTOR EPHA2 PRKACA PRKACB PRKAG1 PRKG2 EPHA7 | 2.57e-04 | 764 | 184 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | D-glucose binding | 2.60e-04 | 14 | 184 | 3 | GO:0005536 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | HK1 HK2 MARK1 RPS6KB1 IRAK2 CAMK1G PFKFB2 PFKL MLKL MET MTOR EPHA2 PRKACA PRKACB PRKAG1 PRKG2 EPHA7 | 3.13e-04 | 709 | 184 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | protein kinase binding | ATG13 PIWIL1 GRIA1 TWF2 TDG PFKFB2 STAT3 MLKL MTOR FZD5 SCN5A PRKACA PRKAG1 C1QBP PRKN PLCB4 DUSP10 PRKG2 CDC25B | 4.63e-04 | 873 | 184 | 19 | GO:0019901 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.67e-04 | 18 | 184 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | glucokinase activity | 8.29e-04 | 5 | 184 | 2 | GO:0004340 | |
| GeneOntologyMolecularFunction | hexokinase activity | 8.29e-04 | 5 | 184 | 2 | GO:0004396 | |
| GeneOntologyMolecularFunction | fructokinase activity | 8.29e-04 | 5 | 184 | 2 | GO:0008865 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 8.29e-04 | 5 | 184 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | AMP binding | 9.06e-04 | 21 | 184 | 3 | GO:0016208 | |
| GeneOntologyMolecularFunction | adrenergic receptor binding | 1.35e-03 | 24 | 184 | 3 | GO:0031690 | |
| GeneOntologyMolecularFunction | protein kinase activity | HK1 MARK1 RPS6KB1 IRAK2 CAMK1G MLKL MET MTOR EPHA2 PRKACA PRKACB PRKAG1 PRKG2 EPHA7 | 1.38e-03 | 600 | 184 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 1.52e-03 | 25 | 184 | 3 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 1.52e-03 | 25 | 184 | 3 | GO:0055056 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | SMARCA5 ABCA2 SMCHD1 DNAH2 PSMC5 SMARCAD1 SMC2 KIF24 ABCA9 DNAH12 TOR1B DNAH5 YME1L1 SMC1B | 1.71e-03 | 614 | 184 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 1.72e-03 | 7 | 184 | 2 | GO:0008443 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.83e-03 | 188 | 184 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | monosaccharide binding | 1.87e-03 | 95 | 184 | 5 | GO:0048029 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 1.91e-03 | 27 | 184 | 3 | GO:0015145 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.13e-03 | 28 | 184 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 2.36e-03 | 29 | 184 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.55e-03 | 102 | 184 | 5 | GO:0001540 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 8.41e-08 | 63 | 183 | 8 | GO:0019228 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 2.90e-07 | 132 | 183 | 10 | GO:0009135 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 2.90e-07 | 132 | 183 | 10 | GO:0009179 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide catabolic process | COL6A1 HK1 HK2 PDE9A XDH PFKFB2 PFKL STAT3 MTOR PRKACA PRKAG1 | 3.40e-07 | 169 | 183 | 11 | GO:0009154 |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | PRPSAP2 COL6A1 EFL1 HK1 HK2 PDE9A ELOVL1 XDH MAGI3 PFKFB2 PFKL STAT3 ADSL MTOR EPHA2 PRKACA PRKAG1 PYGL PRKN | 3.62e-07 | 540 | 183 | 19 | GO:0019693 |
| GeneOntologyBiologicalProcess | nucleotide catabolic process | COL6A1 HK1 HK2 PDE9A XDH TDG PFKFB2 PFKL STAT3 MTOR PRKACA PRKAG1 | 3.63e-07 | 208 | 183 | 12 | GO:0009166 |
| GeneOntologyBiologicalProcess | nucleoside phosphate catabolic process | COL6A1 HK1 HK2 PDE9A XDH TDG PFKFB2 PFKL STAT3 MTOR PRKACA PRKAG1 | 5.43e-07 | 216 | 183 | 12 | GO:1901292 |
| GeneOntologyBiologicalProcess | ribonucleotide catabolic process | COL6A1 HK1 HK2 PDE9A XDH PFKFB2 PFKL STAT3 MTOR PRKACA PRKAG1 | 5.71e-07 | 178 | 183 | 11 | GO:0009261 |
| GeneOntologyBiologicalProcess | glycolytic process | 6.02e-07 | 110 | 183 | 9 | GO:0006096 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 6.09e-07 | 143 | 183 | 10 | GO:0009185 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 7.01e-07 | 112 | 183 | 9 | GO:0019226 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 7.02e-07 | 36 | 183 | 6 | GO:0086010 | |
| GeneOntologyBiologicalProcess | purine nucleotide catabolic process | COL6A1 HK1 HK2 PDE9A XDH PFKFB2 PFKL STAT3 MTOR PRKACA PRKAG1 | 7.12e-07 | 182 | 183 | 11 | GO:0006195 |
| GeneOntologyBiologicalProcess | ADP catabolic process | 8.15e-07 | 114 | 183 | 9 | GO:0046032 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate metabolic process | 8.89e-07 | 149 | 183 | 10 | GO:0009132 | |
| GeneOntologyBiologicalProcess | purine-containing compound catabolic process | COL6A1 HK1 HK2 PDE9A XDH PFKFB2 PFKL STAT3 MTOR PRKACA PRKAG1 | 9.82e-07 | 188 | 183 | 11 | GO:0072523 |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | PRPSAP2 COL6A1 EFL1 ABCA2 HK1 HK2 HTR2C PDE9A PIGK ELOVL1 XDH MAGI3 TDG PIGG PFKFB2 PFKL CPS1 STAT3 ADSL FIG4 MTOR EPHA2 PRKACA PRKAG1 PLA2G4A PYGL PRKN PLCB4 | 9.82e-07 | 1142 | 183 | 28 | GO:0019637 |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 1.01e-06 | 117 | 183 | 9 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 1.01e-06 | 117 | 183 | 9 | GO:0009181 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 1.17e-06 | 119 | 183 | 9 | GO:0019364 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 1.26e-06 | 120 | 183 | 9 | GO:0046031 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 1.35e-06 | 121 | 183 | 9 | GO:0009191 | |
| GeneOntologyBiologicalProcess | organophosphate catabolic process | COL6A1 HK1 HK2 PDE9A XDH TDG PFKFB2 PFKL STAT3 MTOR PRKACA PRKAG1 PLA2G4A | 1.44e-06 | 281 | 183 | 13 | GO:0046434 |
| GeneOntologyBiologicalProcess | germ cell development | PRAMEF7 REC114 ARID4B CATSPERD SMCHD1 RPS6KB1 PIWIL1 PRAMEF8 YTHDC1 BNC1 BRCA2 MTOR PRKACA ASPM MARF1 GNAS CDC25B | 1.49e-06 | 482 | 183 | 17 | GO:0007281 |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 1.54e-06 | 123 | 183 | 9 | GO:0072526 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 1.65e-06 | 124 | 183 | 9 | GO:0009134 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 2.51e-06 | 167 | 183 | 10 | GO:0060048 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | COL6A1 EFL1 HK1 HK2 PDE9A ELOVL1 XDH MAGI3 PFKFB2 PFKL STAT3 ADSL MTOR EPHA2 PRKACA PRKAG1 PRKN | 3.37e-06 | 512 | 183 | 17 | GO:0009150 |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | PRPSAP2 COL6A1 NDST1 EFL1 ABCA2 HK1 HK2 PDE9A PIGK ELOVL1 CHSY1 XDH MAGI3 TDG PIGG PFKFB2 PFKL ITIH3 STAT3 TMTC1 ADSL MTOR EPHA2 PRKACA PRKAG1 PYGL PRKN PLOD1 | 3.88e-06 | 1226 | 183 | 28 | GO:1901135 |
| GeneOntologyBiologicalProcess | striated muscle contraction | RPS6KB1 ACE2 MET MTOR KCNH2 SCN1A SCN2A SCN5A PRKACA SCN8A SCN9A | 3.97e-06 | 217 | 183 | 11 | GO:0006941 |
| GeneOntologyBiologicalProcess | sexual reproduction | PRAMEF7 COL6A1 REC114 ARID4B CATSPERD TOPAZ1 SYNE1 SMCHD1 RPS6KB1 PIWIL1 NBN APOB PRAMEF8 SMC2 YTHDC1 NR2F2 STAT3 BNC1 BRCA2 MTOR PRKACA PRKACB ASPM MARF1 PRKAG1 PLA2G4A GNAS CDC25B SMC1B | 4.81e-06 | 1312 | 183 | 29 | GO:0019953 |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | PRAMEF7 REC114 ARID4B CATSPERD SMCHD1 RPS6KB1 PIWIL1 PRAMEF8 YTHDC1 BNC1 BRCA2 MTOR PRKACA ASPM MARF1 GNAS CDC25B | 4.94e-06 | 527 | 183 | 17 | GO:0022412 |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 5.08e-06 | 142 | 183 | 9 | GO:0006090 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | COL6A1 EFL1 HK1 HK2 PDE9A ELOVL1 XDH MAGI3 PFKFB2 PFKL STAT3 ADSL MTOR EPHA2 PRKACA PRKAG1 PRKN | 5.73e-06 | 533 | 183 | 17 | GO:0009259 |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | PRPSAP2 COL6A1 EFL1 HK1 HK2 SLC2A9 PDE9A ELOVL1 XDH MAGI3 PFKFB2 PFKL STAT3 ADSL MTOR EPHA2 PRKACA PRKAG1 PRKN | 5.82e-06 | 652 | 183 | 19 | GO:0072521 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | CUX2 HTR2C PDE9A SYNE1 RPS6KB1 PSMC5 GRIA1 BCHE STAT3 MET P2RX3 MTOR NSG1 NR2E1 PRKACA PRKN PLCB4 IGSF21 EPHA7 | 7.38e-06 | 663 | 183 | 19 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | CUX2 HTR2C PDE9A SYNE1 RPS6KB1 PSMC5 GRIA1 BCHE STAT3 MET P2RX3 MTOR NSG1 NR2E1 PRKACA PRKN PLCB4 IGSF21 EPHA7 | 7.54e-06 | 664 | 183 | 19 | GO:0099177 |
| GeneOntologyBiologicalProcess | carbohydrate catabolic process | 1.04e-05 | 196 | 183 | 10 | GO:0016052 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | PRPSAP2 COL6A1 EFL1 HK1 HK2 PDE9A ELOVL1 XDH MAGI3 PFKFB2 PFKL STAT3 ADSL MTOR EPHA2 PRKACA PRKAG1 PRKN | 1.07e-05 | 619 | 183 | 18 | GO:0006163 |
| GeneOntologyBiologicalProcess | oogenesis | 1.09e-05 | 156 | 183 | 9 | GO:0048477 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | PRPSAP2 COL6A1 EFL1 HK1 HK2 PDE9A ELOVL1 XDH MAGI3 TDG PFKFB2 PFKL STAT3 ADSL MTOR EPHA2 PRKACA PRKAG1 PRKN | 1.14e-05 | 684 | 183 | 19 | GO:0009117 |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | PRPSAP2 COL6A1 EFL1 HK1 HK2 PDE9A ELOVL1 XDH MAGI3 TDG PFKFB2 PFKL STAT3 ADSL MTOR EPHA2 PRKACA PRKAG1 PRKN | 1.32e-05 | 691 | 183 | 19 | GO:0006753 |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | PRPSAP2 COL6A1 EFL1 HK1 HK2 PDE9A ELOVL1 XDH MAGI3 TDG PFKFB2 PFKL CPS1 STAT3 ADSL MTOR EPHA2 PRKACA PRKAG1 PRKN | 1.67e-05 | 767 | 183 | 20 | GO:0055086 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.83e-05 | 62 | 183 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | female gamete generation | PRAMEF7 REC114 PRAMEF8 YTHDC1 BNC1 BRCA2 ASPM MARF1 PLA2G4A CDC25B | 3.17e-05 | 223 | 183 | 10 | GO:0007292 |
| GeneOntologyBiologicalProcess | carbohydrate derivative catabolic process | COL6A1 HK1 HK2 PDE9A XDH TDG PFKFB2 PFKL STAT3 MTOR PRKACA PRKAG1 | 3.32e-05 | 323 | 183 | 12 | GO:1901136 |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | PRAMEF7 COL6A1 REC114 ARID4B CATSPERD TOPAZ1 SYNE1 SMCHD1 RPS6KB1 PIWIL1 APOB PRAMEF8 YTHDC1 NR2F2 BNC1 BRCA2 MTOR FZD5 PRKACA ASPM MARF1 PRKAG1 PLA2G4A GNAS HSD17B3 CDC25B | 3.64e-05 | 1235 | 183 | 26 | GO:0003006 |
| GeneOntologyBiologicalProcess | purine ribonucleoside triphosphate metabolic process | COL6A1 EFL1 HK1 HK2 PFKFB2 PFKL STAT3 MTOR PRKACA PRKAG1 PRKN | 4.73e-05 | 283 | 183 | 11 | GO:0009205 |
| GeneOntologyBiologicalProcess | ribonucleoside triphosphate metabolic process | COL6A1 EFL1 HK1 HK2 PFKFB2 PFKL STAT3 MTOR PRKACA PRKAG1 PRKN | 5.89e-05 | 290 | 183 | 11 | GO:0009199 |
| GeneOntologyBiologicalProcess | purine nucleoside triphosphate metabolic process | COL6A1 EFL1 HK1 HK2 PFKFB2 PFKL STAT3 MTOR PRKACA PRKAG1 PRKN | 6.07e-05 | 291 | 183 | 11 | GO:0009144 |
| GeneOntologyBiologicalProcess | gamete generation | PRAMEF7 REC114 ARID4B CATSPERD TOPAZ1 SYNE1 SMCHD1 RPS6KB1 PIWIL1 APOB PRAMEF8 YTHDC1 BNC1 BRCA2 MTOR PRKACA ASPM MARF1 PRKAG1 PLA2G4A GNAS CDC25B | 6.20e-05 | 982 | 183 | 22 | GO:0007276 |
| GeneOntologyBiologicalProcess | response to glucagon | 6.56e-05 | 25 | 183 | 4 | GO:0033762 | |
| GeneOntologyBiologicalProcess | carbohydrate phosphorylation | 6.56e-05 | 25 | 183 | 4 | GO:0046835 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | NHLRC1 COL6A1 NDST1 HK1 HK2 MOGAT1 PFKFB2 PFKL SLC2A2 STAT3 PPP1R3A MTOR PRKACA PRKAG1 PLA2G4A PYGL PRKN | 6.61e-05 | 646 | 183 | 17 | GO:0005975 |
| GeneOntologyBiologicalProcess | blood circulation | HTR2C CPS1 ITGA9 NR2F2 POSTN ACE2 MET MTOR KCNH2 SCN1A SCN2A SCN5A PRKACA SCN8A SCN9A C3AR1 GNAS | 6.86e-05 | 648 | 183 | 17 | GO:0008015 |
| GeneOntologyBiologicalProcess | carbohydrate utilization | 7.83e-05 | 2 | 183 | 2 | GO:0009758 | |
| GeneOntologyBiologicalProcess | fructose transmembrane transport | 7.88e-05 | 10 | 183 | 3 | GO:0015755 | |
| GeneOntologyBiologicalProcess | generation of precursor metabolites and energy | NHLRC1 COL6A1 HK1 HK2 SLC25A14 PFKFB2 PFKL STAT3 PPP1R3A ADSL MTOR PRKACA PRKAG1 PYGL GNAS | 7.91e-05 | 529 | 183 | 15 | GO:0006091 |
| GeneOntologyBiologicalProcess | action potential | 8.00e-05 | 201 | 183 | 9 | GO:0001508 | |
| GeneOntologyBiologicalProcess | nicotinamide nucleotide metabolic process | 8.31e-05 | 202 | 183 | 9 | GO:0046496 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide metabolic process | 8.31e-05 | 202 | 183 | 9 | GO:0019362 | |
| GeneOntologyBiologicalProcess | circulatory system process | ABCA2 HTR2C CPS1 ITGA9 NR2F2 POSTN ACE2 MET MTOR KCNH2 SCN1A SCN2A SCN5A PRKACA SCN8A SCN9A C3AR1 GNAS | 9.67e-05 | 733 | 183 | 18 | GO:0003013 |
| GeneOntologyBiologicalProcess | nucleoside triphosphate metabolic process | COL6A1 EFL1 HK1 HK2 PFKFB2 PFKL STAT3 MTOR PRKACA PRKAG1 PRKN | 9.78e-05 | 307 | 183 | 11 | GO:0009141 |
| GeneOntologyBiologicalProcess | ATP metabolic process | 1.04e-04 | 257 | 183 | 10 | GO:0046034 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.04e-04 | 121 | 183 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound metabolic process | 1.12e-04 | 210 | 183 | 9 | GO:0072524 | |
| GeneOntologyBiologicalProcess | muscle system process | COL6A1 PDE9A RPS6KB1 GTF2IRD1 ACE2 MET P2RX3 MTOR KCNH2 SCN1A SCN2A SCN5A PRKACA SCN8A SCN9A | 1.15e-04 | 547 | 183 | 15 | GO:0003012 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.25e-04 | 87 | 183 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | behavior | COL6A1 ABCA2 CUX2 HTR2C RPS6KB1 GRIA1 BCHE STAT3 ACE2 MET P2RX3 FIG4 MTOR SCN1A SCN2A TLR2 NR2E1 SCN8A SCN9A PRKN | 1.33e-04 | 891 | 183 | 20 | GO:0007610 |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 1.34e-04 | 126 | 183 | 7 | GO:0033555 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | COL6A1 CUX2 GIMAP5 SYNE1 GRIA1 MET P2RX3 MTOR KCNH2 SCN1A SCN2A SCN5A SCN8A SCN9A PRKN | 1.45e-04 | 559 | 183 | 15 | GO:0042391 |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | PRAMEF7 REC114 ARID4B CATSPERD TOPAZ1 SYNE1 SMCHD1 RPS6KB1 PIWIL1 APOB PRAMEF8 YTHDC1 NR2F2 BNC1 ACE2 BRCA2 MTOR PRKACA ASPM MARF1 PRKAG1 PLA2G4A GNAS CDC25B | 1.51e-04 | 1194 | 183 | 24 | GO:0048609 |
| GeneOntologyBiologicalProcess | glycolytic process through fructose-6-phosphate | 1.56e-04 | 31 | 183 | 4 | GO:0061615 | |
| GeneOntologyBiologicalProcess | glucose catabolic process | 1.78e-04 | 32 | 183 | 4 | GO:0006007 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.81e-04 | 93 | 183 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | cellular response to glucagon stimulus | 1.84e-04 | 13 | 183 | 3 | GO:0071377 | |
| GeneOntologyBiologicalProcess | muscle contraction | RPS6KB1 ACE2 MET P2RX3 MTOR KCNH2 SCN1A SCN2A SCN5A PRKACA SCN8A SCN9A | 2.49e-04 | 400 | 183 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | meiotic cell cycle | REC114 PIWIL1 NBN SMC2 BRCA2 PRKACA PRKACB ASPM MARF1 CDC25B SMC1B | 3.05e-04 | 350 | 183 | 11 | GO:0051321 |
| GeneOntologyBiologicalProcess | heart contraction | 3.43e-04 | 298 | 183 | 10 | GO:0060047 | |
| GeneOntologyBiologicalProcess | fructose 6-phosphate metabolic process | 3.53e-04 | 16 | 183 | 3 | GO:0006002 | |
| GeneOntologyBiologicalProcess | lipoprotein biosynthetic process | 3.68e-04 | 106 | 183 | 6 | GO:0042158 | |
| GeneOntologyBiologicalProcess | response to carbohydrate | COL6A3 RPS6KB1 APOB PFKFB2 PFKL SLC2A2 P2RX3 GPR68 PRKACA PRKN | 3.71e-04 | 301 | 183 | 10 | GO:0009743 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | CUX2 NRDC GIMAP5 TWF2 ITGAM BNC1 MET KLHL25 MTOR GPR68 TLR2 NR2E1 ASPM DUSP10 GNAS | 3.96e-04 | 614 | 183 | 15 | GO:0010720 |
| GeneOntologyBiologicalProcess | central nervous system development | NDST1 ABCA2 RTN3 GRIA1 ITGAM NR2F2 STAT3 MET BRCA2 RNF103 MTOR BBS7 SCN2A SYNE2 TLR2 SCN5A NR2E1 ARL13B ASPM PRKN DUSP10 DNAH5 EPHA7 | 3.98e-04 | 1197 | 183 | 23 | GO:0007417 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 4.40e-04 | 153 | 183 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | heart process | 4.55e-04 | 309 | 183 | 10 | GO:0003015 | |
| GeneOntologyBiologicalProcess | pachytene | 4.64e-04 | 4 | 183 | 2 | GO:0000239 | |
| GeneOntologyBiologicalProcess | myelination | 5.20e-04 | 206 | 183 | 8 | GO:0042552 | |
| GeneOntologyBiologicalProcess | energy reserve metabolic process | 5.43e-04 | 114 | 183 | 6 | GO:0006112 | |
| GeneOntologyBiologicalProcess | response to nutrient levels | COL6A1 HTR2C RPS6KB1 CHSY1 BCHE RRP8 CPS1 SLC2A2 POSTN ADSL MTOR VPS41 PRKAG1 YME1L1 | 5.47e-04 | 566 | 183 | 14 | GO:0031667 |
| GeneOntologyBiologicalProcess | axon ensheathment | 5.72e-04 | 209 | 183 | 8 | GO:0008366 | |
| GeneOntologyBiologicalProcess | ensheathment of neurons | 5.72e-04 | 209 | 183 | 8 | GO:0007272 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CUX2 HTR2C PDE9A SYNE1 RPS6KB1 PSMC5 GRIA1 BCHE STAT3 MET P2RX3 MTOR NSG1 NR2E1 PRKACA PRKN PLCB4 IGSF21 EPHA7 | 6.39e-04 | 931 | 183 | 19 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CUX2 HTR2C PDE9A SYNE1 RPS6KB1 PSMC5 GRIA1 BCHE STAT3 MET P2RX3 MTOR NSG1 NR2E1 PRKACA PRKN PLCB4 IGSF21 EPHA7 | 6.39e-04 | 931 | 183 | 19 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CUX2 HTR2C PDE9A SYNE1 RPS6KB1 PSMC5 GRIA1 BCHE STAT3 MET P2RX3 MTOR NSG1 NR2E1 PRKACA PRKN PLCB4 IGSF21 EPHA7 | 7.08e-04 | 939 | 183 | 19 | GO:0099537 |
| GeneOntologyBiologicalProcess | positive regulation of insulin secretion | 7.11e-04 | 120 | 183 | 6 | GO:0032024 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | SMARCA5 ARID4B SMCHD1 PIWIL1 RRP8 TDG YTHDC1 TASOR2 GNAS SPTY2D1 | 7.57e-04 | 330 | 183 | 10 | GO:0040029 |
| GeneOntologyBiologicalProcess | negative regulation of dopamine metabolic process | 7.69e-04 | 5 | 183 | 2 | GO:0045963 | |
| GeneOntologyBiologicalProcess | behavioral response to chemical pain | 7.69e-04 | 5 | 183 | 2 | GO:0061366 | |
| GeneOntologyBiologicalProcess | behavioral response to formalin induced pain | 7.69e-04 | 5 | 183 | 2 | GO:0061368 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.84e-07 | 17 | 184 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 5.01e-06 | 29 | 184 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | collagen type VI trimer | 2.30e-04 | 3 | 184 | 2 | GO:0005589 | |
| GeneOntologyCellularComponent | collagen beaded filament | 2.30e-04 | 3 | 184 | 2 | GO:0098647 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MARK1 RPS6KB1 RTN3 GRIA1 HNRNPAB STAT3 MTOR FZD5 SCN2A NSG1 PRKACA SCN8A C1QBP PRKN ARPC5L PLCXD3 PLCB4 EPHA7 | 3.33e-04 | 817 | 184 | 18 | GO:0098978 |
| HumanPheno | Pes valgus | 2.42e-06 | 56 | 82 | 8 | HP:0008081 | |
| HumanPheno | Distal joint hypermobility | 7.39e-06 | 9 | 82 | 4 | HP:0020152 | |
| HumanPheno | Curved toe phalanx | 1.59e-05 | 4 | 82 | 3 | HP:0010176 | |
| HumanPheno | Reduced muscle collagen VI | 1.59e-05 | 4 | 82 | 3 | HP:0030095 | |
| HumanPheno | Reduced maximal expiratory pressure | 1.59e-05 | 4 | 82 | 3 | HP:0012497 | |
| HumanPheno | Increased laxity of fingers | 3.93e-05 | 5 | 82 | 3 | HP:0006149 | |
| HumanPheno | Focal hemiclonic seizure | 3.94e-05 | 25 | 82 | 5 | HP:0006813 | |
| HumanPheno | Complex febrile seizure | 9.80e-05 | 16 | 82 | 4 | HP:0011172 | |
| HumanPheno | Wrist hypermobility | 1.34e-04 | 7 | 82 | 3 | HP:0005072 | |
| HumanPheno | Abnormal muscle fiber protein expression | 1.37e-04 | 32 | 82 | 5 | HP:0030089 | |
| Domain | Na_trans_cytopl | 5.09e-10 | 6 | 183 | 5 | PF11933 | |
| Domain | Na_trans_cytopl | 5.09e-10 | 6 | 183 | 5 | IPR024583 | |
| Domain | Na_channel_asu | 2.07e-08 | 10 | 183 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 2.07e-08 | 10 | 183 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 2.07e-08 | 10 | 183 | 5 | PF06512 | |
| Domain | P-loop_NTPase | EEFSEC NDST1 EFL1 SMARCA5 ABCA2 GIMAP5 DNAH2 PSMC5 MAGI3 SMARCAD1 PFKFB2 RRAS SMC2 KIF24 ABCA9 DNAH12 GTPBP8 ARL13B SULT6B1 ASPM RASL11B TOR1B GNAS DNAH5 YME1L1 RAB27A SMC1B | 6.39e-08 | 848 | 183 | 27 | IPR027417 |
| Domain | - | EEFSEC NDST1 EFL1 SMARCA5 ABCA2 GIMAP5 DNAH2 PSMC5 SMARCAD1 PFKFB2 RRAS SMC2 ABCA9 DNAH12 GTPBP8 ARL13B SULT6B1 RASL11B TOR1B GNAS DNAH5 YME1L1 RAB27A SMC1B | 3.09e-07 | 746 | 183 | 24 | 3.40.50.300 |
| Domain | VWA | 1.20e-06 | 56 | 183 | 7 | PF00092 | |
| Domain | VWFA | 1.58e-05 | 82 | 183 | 7 | PS50234 | |
| Domain | SMC_hinge | 1.81e-05 | 6 | 183 | 3 | SM00968 | |
| Domain | SMC_hinge | 1.81e-05 | 6 | 183 | 3 | PF06470 | |
| Domain | SMC_hinge | 1.81e-05 | 6 | 183 | 3 | IPR010935 | |
| Domain | VWA | 1.85e-05 | 84 | 183 | 7 | SM00327 | |
| Domain | VWF_A | 5.39e-05 | 99 | 183 | 7 | IPR002035 | |
| Domain | - | 8.69e-05 | 74 | 183 | 6 | 3.40.50.410 | |
| Domain | AAA | 8.83e-05 | 144 | 183 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 8.83e-05 | 144 | 183 | 8 | IPR003593 | |
| Domain | IQ | 1.44e-04 | 81 | 183 | 6 | SM00015 | |
| Domain | Channel_four-helix_dom | 2.37e-04 | 57 | 183 | 5 | IPR027359 | |
| Domain | - | 2.37e-04 | 57 | 183 | 5 | 1.20.120.350 | |
| Domain | IQ_motif_EF-hand-BS | 2.57e-04 | 90 | 183 | 6 | IPR000048 | |
| Domain | IQ | 3.07e-04 | 93 | 183 | 6 | PS50096 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.11e-04 | 14 | 183 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 3.11e-04 | 14 | 183 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.11e-04 | 14 | 183 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.11e-04 | 14 | 183 | 3 | IPR011704 | |
| Domain | Sugar/inositol_transpt | 3.11e-04 | 14 | 183 | 3 | IPR003663 | |
| Domain | AAA_8 | 3.11e-04 | 14 | 183 | 3 | PF12780 | |
| Domain | AAA_5 | 3.11e-04 | 14 | 183 | 3 | PF07728 | |
| Domain | DHC_fam | 3.86e-04 | 15 | 183 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 3.86e-04 | 15 | 183 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.86e-04 | 15 | 183 | 3 | IPR004273 | |
| Domain | KASH | 5.66e-04 | 4 | 183 | 2 | IPR012315 | |
| Domain | KASH | 5.66e-04 | 4 | 183 | 2 | PS51049 | |
| Domain | KASH | 5.66e-04 | 4 | 183 | 2 | SM01249 | |
| Domain | KASH | 5.66e-04 | 4 | 183 | 2 | PF10541 | |
| Domain | SUGAR_TRANSPORT_2 | 5.69e-04 | 17 | 183 | 3 | PS00217 | |
| Domain | Ion_trans_dom | 9.06e-04 | 114 | 183 | 6 | IPR005821 | |
| Domain | Ion_trans | 9.06e-04 | 114 | 183 | 6 | PF00520 | |
| Domain | Hexokinase_2 | 9.36e-04 | 5 | 183 | 2 | PF03727 | |
| Domain | SMC | 9.36e-04 | 5 | 183 | 2 | IPR024704 | |
| Domain | Hexokinase_BS | 9.36e-04 | 5 | 183 | 2 | IPR019807 | |
| Domain | Hexokinase_C | 9.36e-04 | 5 | 183 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 9.36e-04 | 5 | 183 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 9.36e-04 | 5 | 183 | 2 | PF00349 | |
| Domain | HEXOKINASE_2 | 9.36e-04 | 5 | 183 | 2 | PS51748 | |
| Domain | HEXOKINASE_1 | 9.36e-04 | 5 | 183 | 2 | PS00378 | |
| Domain | Hexokinase | 1.40e-03 | 6 | 183 | 2 | IPR001312 | |
| Domain | FAT | 1.40e-03 | 6 | 183 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.40e-03 | 6 | 183 | 2 | IPR003151 | |
| Domain | Collagen | 1.49e-03 | 85 | 183 | 5 | IPR008160 | |
| Domain | Collagen | 1.49e-03 | 85 | 183 | 5 | PF01391 | |
| Domain | SUGAR_TRANSPORT_1 | 1.61e-03 | 24 | 183 | 3 | PS00216 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.00e-05 | 98 | 151 | 8 | M39830 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 1.63e-05 | 137 | 151 | 9 | M18155 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.79e-05 | 31 | 151 | 5 | M877 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.07e-05 | 53 | 151 | 6 | MM14566 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.10e-05 | 32 | 151 | 5 | M27455 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.67e-05 | 61 | 151 | 6 | MM14637 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.36e-05 | 20 | 151 | 4 | MM15061 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 6.14e-05 | 64 | 151 | 6 | M26953 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 7.25e-05 | 41 | 151 | 5 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 7.97e-05 | 67 | 151 | 6 | M26999 | |
| Pathway | WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS | 1.02e-04 | 44 | 151 | 5 | M46452 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.02e-04 | 44 | 151 | 5 | M27812 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL4A2 COL6A1 COL6A3 COL6A6 RRAS ITGA9 MET EPHA2 PRKACA PRKACB EPHA7 | 1.16e-04 | 261 | 151 | 11 | MM15676 |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.27e-04 | 46 | 151 | 5 | M198 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY | 1.37e-04 | 10 | 151 | 3 | M47648 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL4A2 COL6A1 COL6A3 COL6A6 PSMC5 RRAS ITGA9 MET EPHA2 SCN1A SCN2A SCN5A PRKACA SCN8A PRKACB SCN9A EPHA7 | 1.43e-04 | 575 | 151 | 17 | M29853 |
| Pathway | WP_THERMOGENESIS | 1.59e-04 | 108 | 151 | 7 | M39746 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | ATG13 XDH GRIA1 ADSL MTOR SCN1A SCN2A SCN5A PRKACA SCN8A PRKACB SCN9A ALDH9A1 | 1.60e-04 | 367 | 151 | 13 | M48346 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.61e-04 | 76 | 151 | 6 | MM14867 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.61e-04 | 76 | 151 | 6 | MM14573 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.83e-04 | 27 | 151 | 4 | M47755 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.90e-04 | 50 | 151 | 5 | MM14796 | |
| Pathway | WP_DRAVET_SYNDROME | 2.12e-04 | 28 | 151 | 4 | M45519 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 2.47e-04 | 12 | 151 | 3 | M27950 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 2.79e-04 | 30 | 151 | 4 | M42578 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.98e-04 | 85 | 151 | 6 | M16441 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.98e-04 | 85 | 151 | 6 | M1870 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 3.18e-04 | 86 | 151 | 6 | M916 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 3.21e-04 | 121 | 151 | 7 | M39823 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.53e-04 | 57 | 151 | 5 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.83e-04 | 58 | 151 | 5 | M2049 | |
| Pathway | WP_DISORDERS_OF_FRUCTOSE_METABOLISM | 4.02e-04 | 14 | 151 | 3 | M45540 | |
| Pathway | KEGG_GAP_JUNCTION | 4.06e-04 | 90 | 151 | 6 | M4013 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.06e-04 | 90 | 151 | 6 | M631 | |
| Pathway | WP_METABOLIC_EPILEPTIC_DISORDERS | 4.31e-04 | 91 | 151 | 6 | M48079 | |
| Pathway | KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM | 4.57e-04 | 34 | 151 | 4 | M15898 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.84e-04 | 61 | 151 | 5 | M27103 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.95e-04 | 130 | 151 | 7 | M27454 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 4.99e-04 | 15 | 151 | 3 | M47794 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 4.99e-04 | 15 | 151 | 3 | M47504 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 6.09e-04 | 16 | 151 | 3 | M47551 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 6.09e-04 | 16 | 151 | 3 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 6.09e-04 | 16 | 151 | 3 | M47650 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 7.03e-04 | 38 | 151 | 4 | MM14969 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 7.34e-04 | 17 | 151 | 3 | M26995 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 7.34e-04 | 17 | 151 | 3 | MM15561 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 7.77e-04 | 39 | 151 | 4 | MM14496 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 9.12e-04 | 70 | 151 | 5 | M8232 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 9.41e-04 | 41 | 151 | 4 | M39655 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 1.03e-03 | 19 | 151 | 3 | M27841 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 1.03e-03 | 19 | 151 | 3 | MM14718 | |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 1.03e-03 | 19 | 151 | 3 | M22004 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.03e-03 | 42 | 151 | 4 | M7169 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.08e-03 | 288 | 151 | 10 | M16864 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 1.12e-03 | 5 | 151 | 2 | M26988 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.13e-03 | 43 | 151 | 4 | M47669 | |
| Pathway | WP_VASOPRESSINREGULATED_WATER_REABSORPTION | 1.23e-03 | 44 | 151 | 4 | M42554 | |
| Pathway | KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION | 1.23e-03 | 44 | 151 | 4 | M9011 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.32e-03 | 76 | 151 | 5 | MM15051 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.32e-03 | 76 | 151 | 5 | M27219 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.34e-03 | 45 | 151 | 4 | M47670 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 1.34e-03 | 45 | 151 | 4 | M39474 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 1.39e-03 | 21 | 151 | 3 | M27058 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.41e-03 | 114 | 151 | 6 | MM14571 | |
| Pubmed | 5.00e-10 | 9 | 185 | 5 | 16382098 | ||
| Pubmed | 5.02e-09 | 13 | 185 | 5 | 15123669 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.15e-08 | 6 | 185 | 4 | 23652591 | |
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 5.34e-08 | 8 | 185 | 4 | 24563484 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRPSAP2 EFL1 HK1 HK2 NRDC POLR2A PSMC5 TWF2 SMARCAD1 PFKL SMC2 HNRNPAB STAT3 ADSL MTOR PRKACA PRKACB C1QBP PLA2G4A PYGL ARPC5L EIF3D BZW1 DCTN4 ALDH9A1 PLOD1 | 6.70e-08 | 1455 | 185 | 26 | 22863883 |
| Pubmed | 9.56e-08 | 9 | 185 | 4 | 15746173 | ||
| Pubmed | 9.56e-08 | 9 | 185 | 4 | 21074528 | ||
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 28518218 | ||
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 32845893 | ||
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 17928448 | ||
| Pubmed | COL4A2 COL6A1 HK2 PIGK SMCHD1 PSMC5 PFKL CPS1 SMC2 HEPH MET TXNDC15 C1QBP TOR1B PLOD1 RAB27A | 2.12e-07 | 613 | 185 | 16 | 22268729 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 3.71e-07 | 12 | 185 | 4 | 30175250 | |
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 17537961 | ||
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 17008315 | ||
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 35031483 | ||
| Pubmed | Hexokinase activity is required for recruitment of parkin to depolarized mitochondria. | 5.90e-07 | 4 | 185 | 3 | 23962723 | |
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 29578003 | ||
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 21156207 | ||
| Pubmed | Reassessment of GLUT7 and GLUT9 as Putative Fructose and Glucose Transporters. | 5.90e-07 | 4 | 185 | 3 | 28083649 | |
| Pubmed | GPCR signaling inhibits mTORC1 via PKA phosphorylation of Raptor. | 5.90e-07 | 4 | 185 | 3 | 31112131 | |
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 18761340 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PRPSAP2 EFL1 SMARCA5 HK1 PIGK POLR2A PSMC5 SMARCAD1 CPS1 SMC2 MTOR EIF3D DCTN4 ALDH9A1 DNAH5 YME1L1 | 1.31e-06 | 704 | 185 | 16 | 29955894 |
| Pubmed | Differential and restricted expression of novel collagen VI chains in mouse. | 1.47e-06 | 5 | 185 | 3 | 21477648 | |
| Pubmed | 1.47e-06 | 5 | 185 | 3 | 17724025 | ||
| Pubmed | 1.47e-06 | 5 | 185 | 3 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.47e-06 | 5 | 185 | 3 | 22875929 | |
| Pubmed | Involvement of protein kinase A in patterning of the mouse somatosensory cortex. | 1.47e-06 | 5 | 185 | 3 | 16707791 | |
| Pubmed | The expanded collagen VI family: new chains and new questions. | 1.47e-06 | 5 | 185 | 3 | 23869615 | |
| Pubmed | PRPSAP2 COL12A1 NRDC PIGK SMCHD1 PSMC5 RTN3 APOB SMARCAD1 PIGG HNRNPAB STAT3 MET TXNDC15 SYNE2 PRKACA TOR1B PLCB4 BZW1 GNAS ALDH9A1 PLOD1 | 1.76e-06 | 1297 | 185 | 22 | 33545068 | |
| Pubmed | 1.91e-06 | 208 | 185 | 9 | 22145905 | ||
| Pubmed | 2.23e-06 | 212 | 185 | 9 | 19521566 | ||
| Pubmed | SMARCA5 HK1 SMCHD1 POLR2A PSMC5 RRP8 TASOR2 MTOR MCM3AP SYNE2 PYGL TAF15 EIF3D PLOD1 SYMPK | 2.49e-06 | 653 | 185 | 15 | 22586326 | |
| Pubmed | EFCAB5 SMARCA5 CUX2 HK1 SYNE1 SMCHD1 RALYL DNAH2 GRIA1 MAGI3 APOB SMC2 HNRNPAB TASOR2 SNRNP48 SYNE2 PRKACA PRKACB SCN9A ASPM MARF1 ARPC5L TAF15 | 2.82e-06 | 1442 | 185 | 23 | 35575683 | |
| Pubmed | Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. | 2.93e-06 | 6 | 185 | 3 | 17557924 | |
| Pubmed | COL4A2 HK1 TMEM237 SYNE1 RTN3 NBN RRP8 SMARCAD1 MET BBS7 EPHA2 SYNE2 ARL13B PRKACA PRKACB ASPM C1QBP TAF15 GNAS ALDH9A1 PLOD1 YME1L1 EPHA7 | 4.68e-06 | 1487 | 185 | 23 | 33957083 | |
| Pubmed | Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). | 5.10e-06 | 7 | 185 | 3 | 18400749 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 5.10e-06 | 7 | 185 | 3 | 25818041 | |
| Pubmed | 5.10e-06 | 7 | 185 | 3 | 9256245 | ||
| Pubmed | Three novel collagen VI chains with high homology to the alpha3 chain. | 5.10e-06 | 7 | 185 | 3 | 18276594 | |
| Pubmed | 5.10e-06 | 7 | 185 | 3 | 15272007 | ||
| Pubmed | 6.34e-06 | 23 | 185 | 4 | 18320585 | ||
| Pubmed | 6.34e-06 | 23 | 185 | 4 | 9730685 | ||
| Pubmed | 6.34e-06 | 23 | 185 | 4 | 9278385 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 6.90e-06 | 86 | 185 | 6 | 28327460 | |
| Pubmed | 7.80e-06 | 187 | 185 | 8 | 26460568 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SMARCA5 HK1 HK2 NRDC SYNE1 SMCHD1 POLR2A PSMC5 RTN3 APOB SMARCAD1 PFKL SMC2 HNRNPAB ADSL MTOR PRKACA C1QBP EIF3D BZW1 GNAS DNAH5 | 7.89e-06 | 1425 | 185 | 22 | 30948266 |
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 21460630 | ||
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 24931163 | ||
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 1.06e-05 | 26 | 185 | 4 | 18500982 | |
| Pubmed | SMARCA5 SMCHD1 POLR2A PSMC5 NBN APOB SMC2 HNRNPAB TGM1 BRCA2 ARPC5L TAF15 GNAS SMC1B | 1.16e-05 | 652 | 185 | 14 | 31180492 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SMARCA5 FAM120B HK1 HK2 SMCHD1 POLR2A PSMC5 SMARCAD1 PFKL SMC2 HNRNPAB TGM1 ADSL MCM3AP ASPM PYGL EIF3D DCTN4 ALDH9A1 PLOD1 YME1L1 | 1.19e-05 | 1353 | 185 | 21 | 29467282 |
| Pubmed | 1.21e-05 | 9 | 185 | 3 | 7688126 | ||
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 1.21e-05 | 9 | 185 | 3 | 17884088 | |
| Pubmed | 1.21e-05 | 9 | 185 | 3 | 19554504 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | SMARCA5 PSMC5 NBN CPS1 SMC2 HNRNPAB TASOR2 ESCO2 YEATS2 TAF15 SPTY2D1 | 1.41e-05 | 411 | 185 | 11 | 35182466 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | SMARCA5 HK1 HK2 SMCHD1 PSMC5 PFKL SMC2 MLKL ADSL PRKACA PRKACB PYGL EIF3D GNAS | 1.45e-05 | 665 | 185 | 14 | 30457570 |
| Pubmed | HIV-1 Tat-peptide inhibits protein kinase C and protein kinase A through substrate competition. | 1.73e-05 | 10 | 185 | 3 | 20433920 | |
| Pubmed | REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. | 2.37e-05 | 11 | 185 | 3 | 15907476 | |
| Pubmed | 2.48e-05 | 32 | 185 | 4 | 23154389 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 21996251 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 2.81e-05 | 2 | 185 | 2 | 37901435 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 15659381 | ||
| Pubmed | Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. | 2.81e-05 | 2 | 185 | 2 | 3023318 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 25600244 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 16407298 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 11792814 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 19694741 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 33448097 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 15760907 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 15760941 | ||
| Pubmed | Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1. | 2.81e-05 | 2 | 185 | 2 | 15963500 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 26746457 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 28082737 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 19401382 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 29307829 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 24675012 | ||
| Pubmed | Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT/mTOR/STAT3 signaling. | 2.81e-05 | 2 | 185 | 2 | 26191214 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 33188786 | ||
| Pubmed | Protein kinase A modulates Cdc25B activity during meiotic resumption of mouse oocytes. | 2.81e-05 | 2 | 185 | 2 | 19035343 | |
| Pubmed | Transglutaminase-1 regulates renal epithelial cell proliferation through activation of Stat-3. | 2.81e-05 | 2 | 185 | 2 | 19049964 | |
| Pubmed | Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells. | 2.81e-05 | 2 | 185 | 2 | 25061101 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 15800055 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 36152045 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 31943325 | ||
| Pubmed | CDC25B acts as a potential target of PRKACA in fertilized mouse eggs. | 2.81e-05 | 2 | 185 | 2 | 18633139 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 18779368 | ||
| Pubmed | Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. | 2.81e-05 | 2 | 185 | 2 | 15899889 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 15838885 | ||
| Pubmed | The mTOR pathway is necessary for survival of mice with short telomeres. | 2.81e-05 | 2 | 185 | 2 | 32127537 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 15067069 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 26109178 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 29305864 | ||
| Pubmed | The FRB domain of mTOR: NMR solution structure and inhibitor design. | 2.81e-05 | 2 | 185 | 2 | 16922504 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 18767117 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 18601978 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 21504994 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 19936974 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 25063062 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 2833513 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 16452250 | ||
| Interaction | SCN11A interactions | 7.78e-06 | 15 | 180 | 4 | int:SCN11A | |
| Interaction | COLQ interactions | 1.04e-05 | 33 | 180 | 5 | int:COLQ | |
| Cytoband | 3q26.1-q26.2 | 4.83e-05 | 3 | 185 | 2 | 3q26.1-q26.2 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.52e-09 | 9 | 121 | 5 | 1203 | |
| GeneFamily | Collagens | 1.36e-05 | 46 | 121 | 5 | 490 | |
| GeneFamily | Dyneins, axonemal | 1.86e-04 | 17 | 121 | 3 | 536 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.64e-04 | 4 | 121 | 2 | 1252 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 9.13e-04 | 7 | 121 | 2 | 761 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 1.40e-06 | 199 | 182 | 10 | M9568 | |
| Coexpression | GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 2.31e-06 | 164 | 182 | 9 | M7633 | |
| Coexpression | NABA_COLLAGENS | 1.19e-05 | 43 | 182 | 5 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 1.33e-05 | 44 | 182 | 5 | M3005 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | COL12A1 PDE9A RPS6KB1 XDH GRIA1 RRP8 ITGA9 ABCA9 HNRNPAB NR2F2 ESCO2 POSTN ACE2 TMTC1 SNRNP48 SCN1A SCN2A NSG1 SERTAD4 PLA2G4A SPTY2D1 | 6.50e-06 | 819 | 180 | 21 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | HK2 SMC2 ITGA9 RCOR2 ESCO2 POSTN MLKL BRCA2 SYNE2 ASPM PLA2G4A PYGL ARHGAP28 PLCB4 | 1.12e-05 | 410 | 180 | 14 | GSM791122_500 |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | COL4A2 COL6A1 COL6A3 COL6A6 NR2F2 HEPH ITIH3 BNC1 POSTN SCN5A | 6.51e-09 | 187 | 185 | 10 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COL4A2 COL6A1 COL6A3 COL12A1 MARK1 BCHE ITGA9 HEPH POSTN ARHGAP28 | 6.51e-09 | 187 | 185 | 10 | c104fbfef2d0bef64077ac721edf2379fd59d547 |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | COL4A2 COL6A1 COL6A3 COL12A1 MARK1 BCHE ITGA9 HEPH POSTN ARHGAP28 | 7.21e-09 | 189 | 185 | 10 | 44e37f88137bb249933eb615235b2cf2ae7f3925 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COL6A1 COL6A3 COL12A1 MARK1 BCHE ITGA9 NR2F2 HEPH POSTN ARHGAP28 | 8.38e-09 | 192 | 185 | 10 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | COL4A2 COL6A1 COL6A3 MXRA5 COL12A1 COL6A6 ABCA9 HEPH BNC1 POSTN | 1.02e-08 | 196 | 185 | 10 | 275e153347caf94edc0c50021bbab49c8696fecb |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | COL4A2 COL6A3 COL12A1 CAMK1G ABCA9 NR2F2 TMTC1 PLA2G4A PLCXD3 | 9.34e-08 | 187 | 185 | 9 | 76bfe8c42430a230a8bdf299575c444fb7780f24 |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | COL4A2 COL6A3 COL12A1 CAMK1G ABCA9 NR2F2 TMTC1 PLA2G4A PLCXD3 | 1.34e-07 | 195 | 185 | 9 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL6A1 COL6A3 COL12A1 MARK1 ITGA9 POSTN TMTC1 RASL11B DUSP10 | 1.46e-07 | 197 | 185 | 9 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL6A1 COL6A3 COL12A1 MARK1 ITGA9 POSTN TMTC1 RASL11B DUSP10 | 1.46e-07 | 197 | 185 | 9 | 155e63b33302a87393ace699b2f6d73abe9c5763 |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL6A1 COL6A3 COL12A1 MARK1 ITGA9 POSTN TMTC1 RASL11B DUSP10 | 1.52e-07 | 198 | 185 | 9 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.59e-07 | 199 | 185 | 9 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 1.59e-07 | 199 | 185 | 9 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.66e-07 | 200 | 185 | 9 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.26e-07 | 175 | 185 | 8 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-07 | 177 | 185 | 8 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-07 | 177 | 185 | 8 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.25e-07 | 178 | 185 | 8 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.36e-07 | 181 | 185 | 8 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-06 | 188 | 185 | 8 | f5102e8d95506c25c675094b86162a6a50087b64 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 191 | 185 | 8 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 191 | 185 | 8 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.40e-06 | 191 | 185 | 8 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.40e-06 | 191 | 185 | 8 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 192 | 185 | 8 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 192 | 185 | 8 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.57e-06 | 194 | 185 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 194 | 185 | 8 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 195 | 185 | 8 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 195 | 185 | 8 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-06 | 195 | 185 | 8 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 1.70e-06 | 196 | 185 | 8 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 197 | 185 | 8 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 197 | 185 | 8 | 43b5f8e917506c1717f9311584901b506ffd2c79 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-06 | 197 | 185 | 8 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 197 | 185 | 8 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-06 | 198 | 185 | 8 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.83e-06 | 198 | 185 | 8 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.90e-06 | 199 | 185 | 8 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-06 | 199 | 185 | 8 | a60880d6b73b2f33b33790873b8c1e8096863908 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.90e-06 | 199 | 185 | 8 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.90e-06 | 199 | 185 | 8 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.90e-06 | 199 | 185 | 8 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.90e-06 | 199 | 185 | 8 | caf2e050b21e7a16ce4e51b3f135debd06810231 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-06 | 200 | 185 | 8 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 185 | 8 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 1.98e-06 | 200 | 185 | 8 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 185 | 8 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 185 | 8 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 185 | 8 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 185 | 8 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.98e-06 | 200 | 185 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | severe-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.98e-06 | 200 | 185 | 8 | 5ee43386da8261d2e7602a152e6ba4338d844e08 | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.98e-06 | 200 | 185 | 8 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 185 | 8 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.18e-06 | 150 | 185 | 7 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-06 | 161 | 185 | 7 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-06 | 161 | 185 | 7 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.50e-06 | 163 | 185 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | Influenza_Severe-cDC|World / Disease group and Cell class | 5.73e-06 | 164 | 185 | 7 | c984228f73b9aa1aaf948541f64f41ed874770cd | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-pDC|Liver / Manually curated celltypes from each tissue | 6.20e-06 | 166 | 185 | 7 | 24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 7.82e-06 | 172 | 185 | 7 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.76e-06 | 175 | 185 | 7 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.76e-06 | 175 | 185 | 7 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.76e-06 | 175 | 185 | 7 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.09e-06 | 176 | 185 | 7 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.43e-06 | 177 | 185 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.43e-06 | 177 | 185 | 7 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.43e-06 | 177 | 185 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.43e-06 | 177 | 185 | 7 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-06 | 178 | 185 | 7 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-06 | 178 | 185 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-06 | 178 | 185 | 7 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 179 | 185 | 7 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-05 | 180 | 185 | 7 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 181 | 185 | 7 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 181 | 185 | 7 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.13e-05 | 182 | 185 | 7 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 1.17e-05 | 183 | 185 | 7 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-05 | 183 | 185 | 7 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.26e-05 | 185 | 185 | 7 | d747bc91fc276f12a5572ab0223fc71f829a5110 | |
| ToppCell | saliva-Severe-critical_progression_d28-40|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-05 | 186 | 185 | 7 | 0095560ca776b01aa473ad4d6015ed78fc93ff51 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.30e-05 | 186 | 185 | 7 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 187 | 185 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 187 | 185 | 7 | e53471c3e146a6f54788d81ecc469aba55b051bb | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 187 | 185 | 7 | e176b5b051690f840f3b12c8f7c4cc10cbe2bbae | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 187 | 185 | 7 | 6ab51e17a7782c2ae6394cad813dc3a2cde70c89 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 187 | 185 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 187 | 185 | 7 | 3d7d51fbadb20dc884d0b3c0d61b80f022b19d09 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.39e-05 | 188 | 185 | 7 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.39e-05 | 188 | 185 | 7 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-05 | 188 | 185 | 7 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.44e-05 | 189 | 185 | 7 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.44e-05 | 189 | 185 | 7 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.44e-05 | 189 | 185 | 7 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.44e-05 | 189 | 185 | 7 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 190 | 185 | 7 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 1.49e-05 | 190 | 185 | 7 | 005967c540418b85311308072a07c684f4296aef | |
| Drug | glycogen | NHLRC1 HK1 HK2 SLC2A9 ARID4B SLC2A7 RPS6KB1 APOB PFKFB2 PFKL SLC2A2 PPP1R3A MTOR PRKACA PRKACB PRKAG1 PYGL | 1.39e-07 | 443 | 185 | 17 | CID000439177 |
| Drug | chloroquine | SLC2A9 SLC2A7 IRAK2 TWF2 ITGAM SLC2A2 ACE2 KCNH2 TLR2 PRKAG1 C1QBP C3AR1 YME1L1 | 7.23e-07 | 288 | 185 | 13 | CID000002719 |
| Drug | acadesine | 9.24e-07 | 126 | 185 | 9 | CID000017513 | |
| Drug | T-Pg | 1.26e-06 | 43 | 185 | 6 | CID006323525 | |
| Drug | AC1L19C4 | 1.47e-06 | 69 | 185 | 7 | CID000000483 | |
| Drug | Isoproterenol | CUX2 HK2 ARID4B RPS6KB1 ELOVL1 XDH NBN TDG CPS1 ITGAM HEPH ITIH3 STAT3 POSTN ACE2 TMTC1 RNF103 MTOR SCN5A PLA2G4A PYGL PLCB4 GNAS RAB27A | 2.74e-06 | 1016 | 185 | 24 | ctd:D007545 |
| Drug | milrinone | 3.94e-06 | 150 | 185 | 9 | CID000004197 | |
| Drug | genistein | COL6A3 GIMAP5 RPS6KB1 CHSY1 BCHE APOB SMC2 ITGA9 ITGAM HNRNPAB STAT3 MLKL MET SLC9A2 BRCA2 MTOR KCNH2 PRKACA PRKACB PLA2G4A PLCXD3 PLCB4 PRKG2 PLOD1 YME1L1 | 4.32e-06 | 1117 | 185 | 25 | CID005280961 |
| Drug | GF109203X | HTR2C RPS6KB1 SLC2A2 TGM1 MTOR KCNH2 GPR68 PRKACA PRKACB PLA2G4A PLCXD3 PLCB4 PRKG2 | 4.67e-06 | 341 | 185 | 13 | CID000002396 |
| Drug | 2,5-anhydro-D-mannitol | 4.80e-06 | 31 | 185 | 5 | CID000001494 | |
| Drug | Azathioprine | MXRA5 HK1 HK2 TMEM237 RPS6KB1 XDH SMC2 SLC2A2 NR2F2 STAT3 ESCO2 MLKL MET BRCA2 MTOR SCN1A TLR2 ASPM | 5.05e-06 | 639 | 185 | 18 | ctd:D001379 |
| Drug | alitretinoin | COL4A2 COL6A1 COL12A1 MARK1 RPS6KB1 ITGAM SLC2A2 MET TGM1 MTOR DUSP10 RAB27A | 6.98e-06 | 301 | 185 | 12 | ctd:C103303 |
| Drug | 2-(aminomethyl)pyrrolidine | 7.02e-06 | 161 | 185 | 9 | CID000072032 | |
| Drug | 2-hexulofuranose | 7.61e-06 | 88 | 185 | 7 | CID000000716 | |
| Drug | AICAR monophosphate | 7.76e-06 | 163 | 185 | 9 | CID000000200 | |
| Drug | Zonisamide | 9.25e-06 | 17 | 185 | 4 | DB00909 | |
| Drug | arabinopyranose | COL6A3 HK1 SLC2A7 XDH SLC2A2 ESCO2 POSTN ACE2 TMTC1 PYGL YME1L1 | 1.01e-05 | 261 | 185 | 11 | CID000000229 |
| Drug | APETx1, Anthopleura elegantissima | 1.04e-05 | 6 | 185 | 3 | ctd:C475726 | |
| Drug | bromopyruvate | 1.18e-05 | 18 | 185 | 4 | ctd:C017092 | |
| Drug | 1,6-di-o-phosphonohexopyranose | 1.35e-05 | 64 | 185 | 6 | CID000000737 | |
| Drug | sibutramine | 1.75e-05 | 40 | 185 | 5 | CID000005210 | |
| Drug | Tetrodotoxin | 1.75e-05 | 40 | 185 | 5 | ctd:D013779 | |
| Drug | 6-o-phosphonohexose | 2.14e-05 | 185 | 185 | 9 | CID000099058 | |
| Drug | spermine | NRDC POLR2A XDH GRIA1 TGM1 SCN2A ASPM PYGL PLCXD3 PLCB4 PRKG2 RAB27A SYMPK | 2.17e-05 | 394 | 185 | 13 | CID000001103 |
| Drug | ATP,Gamma S | 2.53e-05 | 189 | 185 | 9 | CID000002028 | |
| Drug | sodium chloride | COL6A1 COL6A3 SMARCA5 COL12A1 HK1 HK2 SLC2A9 ARID4B SLC2A7 PFKFB2 PFKL SLC2A2 POSTN P2RX3 EPHA2 PRKACA PRKACB PRKAG1 PYGL GNAS | 2.68e-05 | 865 | 185 | 20 | CID000000206 |
| Drug | U285 | 2.92e-05 | 108 | 185 | 7 | CID000009475 | |
| Drug | sodium | SLC2A9 PDE9A SLC2A7 SLC26A9 GRIA1 BCHE TDG SLC2A2 MET SLC9A2 P2RX3 MTOR KCNH2 EPHA2 SCN2A SCN5A PRKACA PRKACB SCN9A PRKG2 YME1L1 | 2.94e-05 | 944 | 185 | 21 | CID000000923 |
| Drug | 2-deoxy-D-galactopyranose | 3.28e-05 | 110 | 185 | 7 | CID000000040 | |
| Drug | hydroxyl radicals | PRPSAP2 COL6A3 EFL1 HK1 HK2 MOGAT1 PDE9A PIGK USP29 SLC26A9 XDH BCHE PFKFB2 PFKL CPS1 PPP1R3A TGM1 RASA4 PRKACA PRKACB PLA2G4A PLCB4 DUSP10 ALDH9A1 CDC25B PLOD1 | 3.36e-05 | 1341 | 185 | 26 | CID000000961 |
| Drug | polyribosylribitol phosphate | 3.69e-05 | 112 | 185 | 7 | CID000002219 | |
| Drug | glutamate | PRPSAP2 PHYKPL HK1 HK2 ARID4B APTX GRIA1 TDG PFKL CPS1 P2RX3 MTOR SCN9A TAS1R1 PRKN PLCXD3 PLCB4 GNAS ALDH9A1 PLOD1 YME1L1 | 3.86e-05 | 962 | 185 | 21 | CID000000611 |
| Drug | AC1Q6RZL | 3.90e-05 | 47 | 185 | 5 | CID000001144 | |
| Drug | Mexiletine | 4.28e-05 | 9 | 185 | 3 | ctd:D008801 | |
| Drug | rolipram | 4.44e-05 | 253 | 185 | 10 | CID000005092 | |
| Drug | PDEs | 4.62e-05 | 116 | 185 | 7 | CID003036959 | |
| Drug | 9-beta-D-arabinofuranosylguanine | EEFSEC PDE9A RPS6KB1 SLC25A14 XDH TWF2 RRAS STAT3 TGM1 MTOR RASA4 PRKACA PRKACB VPS41 PYGL PLCXD3 PLCB4 PRKG2 GNAS | 6.05e-05 | 843 | 185 | 19 | CID000000765 |
| Drug | oxepin | 6.07e-05 | 10 | 185 | 3 | CID006451477 | |
| Drug | Sodium | 6.38e-05 | 84 | 185 | 6 | ctd:D012964 | |
| Drug | Bplplp | 6.40e-05 | 27 | 185 | 4 | CID000125628 | |
| Drug | Ranolazine | 6.57e-05 | 2 | 185 | 2 | DB00243 | |
| Drug | Phenytoin | 6.57e-05 | 2 | 185 | 2 | DB00252 | |
| Drug | Propafenone | 6.57e-05 | 2 | 185 | 2 | DB01182 | |
| Drug | profenamine | 6.57e-05 | 2 | 185 | 2 | ctd:C084820 | |
| Drug | 18-methoxycoronaridine | 6.57e-05 | 2 | 185 | 2 | ctd:C103345 | |
| Drug | Ajmaline | 6.57e-05 | 2 | 185 | 2 | ctd:D000404 | |
| Drug | NSC521040 | 6.71e-05 | 123 | 185 | 7 | CID000001041 | |
| Drug | AC1Q6RZ4 | 6.71e-05 | 123 | 185 | 7 | CID000000719 | |
| Drug | AC1L494B | 7.02e-05 | 53 | 185 | 5 | CID000181487 | |
| Drug | AC1L9R2Z | 7.18e-05 | 168 | 185 | 8 | CID000453624 | |
| Drug | glibenclamide | ABCA2 HK1 SLC26A9 APOB ABCA9 SLC2A2 PPP1R3A KCNH2 PRKACA PRKACB PRKG2 YME1L1 | 7.24e-05 | 382 | 185 | 12 | CID000003488 |
| Drug | Laevuflex | 8.12e-05 | 272 | 185 | 10 | CID000003426 | |
| Drug | V0509 | 8.12e-05 | 272 | 185 | 10 | CID000102191 | |
| Drug | AC1MBZ1C | RPS6KB1 GRIA1 CAMK1G SLC9A2 ADSL PRKACA PRKACB PLA2G4A PRKG2 GNAS YME1L1 RAB27A | 8.19e-05 | 387 | 185 | 12 | CID000003541 |
| Drug | AC1L1IIA | 8.47e-05 | 172 | 185 | 8 | CID000004591 | |
| Drug | 1-o-phosphonohex-2-ulose | 8.55e-05 | 29 | 185 | 4 | CID000000481 | |
| Drug | NSC99363 | 9.38e-05 | 90 | 185 | 6 | CID000414014 | |
| Drug | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | COL6A3 HK2 TMEM237 IRAK2 XDH MAGI3 ABCA9 TSPAN33 POSTN MET EPHA2 SYNE2 PLA2G4A RASL11B ARHGAP28 PLCB4 PRKG2 EPHA7 | 1.09e-04 | 807 | 185 | 18 | ctd:C548651 |
| Drug | 8-bromoadenosine | 1.10e-04 | 133 | 185 | 7 | CID000096544 | |
| Drug | PDE II | 1.13e-04 | 93 | 185 | 6 | CID003047060 | |
| Drug | Thimerosal | HK1 HK2 HTR2C NRDC ATG13 TTC39C SMCHD1 USP29 PFKFB2 CPS1 HEPH RCOR2 TSPAN33 TASOR2 ESCO2 MROH1 BRCA2 SYNE2 ASPM PYGL PLCB4 FRMPD3 PLOD1 | 1.16e-04 | 1199 | 185 | 23 | ctd:D013849 |
| Drug | Zinc Sulfate | PRPSAP2 COL6A3 HK1 HK2 PSMC5 XDH PFKFB2 PFKL STAT3 MET SCN1A SERTAD4 PLA2G4A PLCB4 FRMPD3 GNAS EPHA7 | 1.17e-04 | 739 | 185 | 17 | ctd:D019287 |
| Drug | 2,3-DPG | 1.32e-04 | 137 | 185 | 7 | CID000000061 | |
| Drug | 2-ethoxyethanol | 1.38e-04 | 61 | 185 | 5 | ctd:C021296 | |
| Drug | 3-OMG | 1.44e-04 | 33 | 185 | 4 | CID000097217 | |
| Drug | DMPD | 1.44e-04 | 33 | 185 | 4 | CID000007472 | |
| Drug | glyceraldehyde | 1.51e-04 | 140 | 185 | 7 | CID000000751 | |
| Drug | Dopamine | 1.59e-04 | 240 | 185 | 9 | ctd:D004298 | |
| Drug | Tn-1 | 1.62e-04 | 34 | 185 | 4 | CID005321959 | |
| Drug | NSC15627 | 1.62e-04 | 34 | 185 | 4 | CID000002073 | |
| Drug | KT5720 | 1.63e-04 | 189 | 185 | 8 | CID000003844 | |
| Drug | methyl cellosolve | 1.67e-04 | 297 | 185 | 10 | ctd:C005219 | |
| Drug | 1 sulfonylurea | 1.72e-04 | 143 | 185 | 7 | CID011819083 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.70e-09 | 10 | 175 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.70e-09 | 10 | 175 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | CUX2 HTR2C PDE9A SYNE1 GRIA1 BCHE PFKL ITGA9 ITGAM ITIH3 BRCA2 SCN2A TLR2 NR2E1 SCN8A PLA2G4A PLCXD3 | 4.34e-09 | 477 | 175 | 17 | C0005586 |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.31e-09 | 12 | 175 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Ullrich congenital muscular dystrophy 1 | 8.17e-07 | 4 | 175 | 3 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 8.17e-07 | 4 | 175 | 3 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 8.17e-07 | 4 | 175 | 3 | cv:C4551860 | |
| Disease | Bethlem myopathy | 8.17e-07 | 4 | 175 | 3 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 8.17e-07 | 4 | 175 | 3 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 8.17e-07 | 4 | 175 | 3 | DOID:0050558 (is_implicated_in) | |
| Disease | Intellectual Disability | NDST1 CUX2 HK1 SYNE1 GRIA1 ACE2 ADSL MTOR BBS7 SCN1A ARL13B SCN8A GNAS | 2.97e-06 | 447 | 175 | 13 | C3714756 |
| Disease | hyperuricemia (implicated_via_orthology) | 7.05e-06 | 7 | 175 | 3 | DOID:1920 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 8.04e-06 | 22 | 175 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.68e-05 | 9 | 175 | 3 | C3502809 | |
| Disease | ovarian cancer (is_implicated_in) | 2.07e-05 | 56 | 175 | 5 | DOID:2394 (is_implicated_in) | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 3.50e-05 | 2 | 175 | 2 | C4551549 | |
| Disease | Ullrich congenital muscular dystrophy (implicated_via_orthology) | 3.50e-05 | 2 | 175 | 2 | DOID:0050558 (implicated_via_orthology) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 5.61e-05 | 13 | 175 | 3 | C0751122 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 7.58e-05 | 171 | 175 | 7 | DOID:9352 (is_implicated_in) | |
| Disease | pancreatitis (biomarker_via_orthology) | 8.36e-05 | 39 | 175 | 4 | DOID:4989 (biomarker_via_orthology) | |
| Disease | Benign familial infantile epilepsy | 1.05e-04 | 3 | 175 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 1.05e-04 | 3 | 175 | 2 | C0032768 | |
| Disease | gastrinoma (is_marker_for) | 1.05e-04 | 3 | 175 | 2 | DOID:5577 (is_marker_for) | |
| Disease | Endocrine System Diseases | 1.05e-04 | 3 | 175 | 2 | C0014130 | |
| Disease | Torsades de Pointes | 1.05e-04 | 3 | 175 | 2 | C0040479 | |
| Disease | B Virus Infection | 1.05e-04 | 3 | 175 | 2 | C0037140 | |
| Disease | persistent fetal circulation syndrome (is_implicated_in) | 1.05e-04 | 3 | 175 | 2 | DOID:13042 (is_implicated_in) | |
| Disease | Herpesviridae Infections | 1.05e-04 | 3 | 175 | 2 | C0019372 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 1.85e-04 | 19 | 175 | 3 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.08e-04 | 4 | 175 | 2 | cv:CN293514 | |
| Disease | Malignant neoplasm of breast | SYNE1 RALYL XDH NBN BCHE ITGA9 SLC2A2 STAT3 PPP1R3A SLC9A2 TXNDC15 BRCA2 MTOR SYNE2 C1QBP PLA2G4A PLOD1 | 2.36e-04 | 1074 | 175 | 17 | C0006142 |
| Disease | sex interaction measurement, bilirubin measurement | 2.91e-04 | 22 | 175 | 3 | EFO_0004570, EFO_0008343 | |
| Disease | Carcinoma of lung | 3.33e-04 | 23 | 175 | 3 | C0684249 | |
| Disease | Cerebellar Ataxia | 3.46e-04 | 5 | 175 | 2 | C0007758 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 3.46e-04 | 5 | 175 | 2 | C0410190 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 3.46e-04 | 5 | 175 | 2 | C1450051 | |
| Disease | brain ischemia (biomarker_via_orthology) | 3.63e-04 | 102 | 175 | 5 | DOID:2316 (biomarker_via_orthology) | |
| Disease | Neoplasm of the genitourinary tract | 3.79e-04 | 24 | 175 | 3 | cv:C0042065 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.79e-04 | 24 | 175 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.79e-04 | 24 | 175 | 3 | C3805278 | |
| Disease | Amyotrophic Lateral Sclerosis | 3.95e-04 | 58 | 175 | 4 | C0002736 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 4.15e-04 | 105 | 175 | 5 | DOID:9352 (implicated_via_orthology) | |
| Disease | Ataxia | 4.28e-04 | 25 | 175 | 3 | C0004134 | |
| Disease | epilepsy (implicated_via_orthology) | 4.40e-04 | 163 | 175 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Lymphatic Metastasis | 4.82e-04 | 26 | 175 | 3 | C0024232 | |
| Disease | Cholangiocarcinoma | 4.82e-04 | 26 | 175 | 3 | C0206698 | |
| Disease | Emery-Dreifuss muscular dystrophy | 5.16e-04 | 6 | 175 | 2 | cv:C0410189 | |
| Disease | Lennox-Gastaut syndrome | 5.16e-04 | 6 | 175 | 2 | C0238111 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 5.16e-04 | 6 | 175 | 2 | C0410189 | |
| Disease | Familial benign neonatal epilepsy | 5.16e-04 | 6 | 175 | 2 | C0220669 | |
| Disease | familial hyperlipidemia (is_marker_for) | 5.16e-04 | 6 | 175 | 2 | DOID:1168 (is_marker_for) | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 5.16e-04 | 6 | 175 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Glycogen Storage Disease | 5.40e-04 | 27 | 175 | 3 | C0017919 | |
| Disease | CCL5 measurement | 5.76e-04 | 64 | 175 | 4 | EFO_0005117 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 6.02e-04 | 28 | 175 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | Neurotoxicity Syndromes | 6.69e-04 | 29 | 175 | 3 | C0235032 | |
| Disease | Encephalopathy, Toxic | 6.69e-04 | 29 | 175 | 3 | C0149504 | |
| Disease | Toxic Encephalitis | 6.69e-04 | 29 | 175 | 3 | C0154659 | |
| Disease | prostate cancer (is_implicated_in) | 6.79e-04 | 117 | 175 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | long QT syndrome (is_implicated_in) | 7.20e-04 | 7 | 175 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | Seizure, Febrile, Complex | 7.20e-04 | 7 | 175 | 2 | C0751057 | |
| Disease | Hyperuricemia | 7.20e-04 | 7 | 175 | 2 | C0740394 | |
| Disease | neutropenia (implicated_via_orthology) | 7.20e-04 | 7 | 175 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 7.20e-04 | 7 | 175 | 2 | C0751337 | |
| Disease | Seizure, Febrile, Simple | 7.20e-04 | 7 | 175 | 2 | C0149886 | |
| Disease | Hyperkinesia | 8.96e-04 | 32 | 175 | 3 | C3887506 | |
| Disease | Hyperkinesia, Generalized | 8.96e-04 | 32 | 175 | 3 | C0751217 | |
| Disease | Muscular Dystrophy | 9.57e-04 | 8 | 175 | 2 | C0026850 | |
| Disease | Idiopathic Myoclonic Epilepsy | 9.57e-04 | 8 | 175 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 9.57e-04 | 8 | 175 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 9.57e-04 | 8 | 175 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 9.57e-04 | 8 | 175 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 9.57e-04 | 8 | 175 | 2 | C0393703 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 9.57e-04 | 8 | 175 | 2 | C0393695 | |
| Disease | Autistic Disorder | 9.80e-04 | 261 | 175 | 7 | C0004352 | |
| Disease | Malignant Neoplasms | 1.02e-03 | 128 | 175 | 5 | C0006826 | |
| Disease | Colorectal Carcinoma | SYNE1 RPS6KB1 PSMC5 APOB ABCA9 POSTN MCM3AP TLR2 GNAS IGSF21 VWA2 EPHA7 | 1.04e-03 | 702 | 175 | 12 | C0009402 |
| Disease | lung disease (biomarker_via_orthology) | 1.17e-03 | 35 | 175 | 3 | DOID:850 (biomarker_via_orthology) | |
| Disease | urinary bladder cancer (implicated_via_orthology) | 1.23e-03 | 9 | 175 | 2 | DOID:11054 (implicated_via_orthology) | |
| Disease | Febrile Convulsions | 1.23e-03 | 9 | 175 | 2 | C0009952 | |
| Disease | glycogen storage disease (is_implicated_in) | 1.23e-03 | 9 | 175 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | Myoclonic Epilepsy | 1.23e-03 | 9 | 175 | 2 | C0014550 | |
| Disease | Gout | 1.23e-03 | 9 | 175 | 2 | C0018099 | |
| Disease | ovarian neoplasm | 1.25e-03 | 134 | 175 | 5 | C0919267 | |
| Disease | Glioblastoma | 1.27e-03 | 79 | 175 | 4 | C0017636 | |
| Disease | Malignant neoplasm of ovary | 1.38e-03 | 137 | 175 | 5 | C1140680 | |
| Disease | Obesity | 1.45e-03 | 205 | 175 | 6 | C0028754 | |
| Disease | congestive heart failure (is_marker_for) | 1.46e-03 | 82 | 175 | 4 | DOID:6000 (is_marker_for) | |
| Disease | Profound Mental Retardation | 1.47e-03 | 139 | 175 | 5 | C0020796 | |
| Disease | Mental deficiency | 1.47e-03 | 139 | 175 | 5 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 1.47e-03 | 139 | 175 | 5 | C0025363 | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 1.53e-03 | 10 | 175 | 2 | DOID:7693 (is_marker_for) | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.53e-03 | 10 | 175 | 2 | C0917800 | |
| Disease | Atrophic | 1.53e-03 | 10 | 175 | 2 | C0333641 | |
| Disease | Giant Cell Glioblastoma | 1.59e-03 | 84 | 175 | 4 | C0334588 | |
| Disease | colon cancer (biomarker_via_orthology) | 1.60e-03 | 39 | 175 | 3 | DOID:219 (biomarker_via_orthology) | |
| Disease | body surface area | COL6A1 SMCHD1 CHSY1 GRIA1 CPS1 ADSL MTOR KCNH2 PRKG2 GNAS SYMPK | 1.66e-03 | 643 | 175 | 11 | EFO_0022196 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.77e-03 | 145 | 175 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | epilepsy | 1.85e-03 | 41 | 175 | 3 | EFO_0000474 | |
| Disease | congestive heart failure (implicated_via_orthology) | 1.85e-03 | 41 | 175 | 3 | DOID:6000 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FIRVSGSELVQKFIG | 211 | P62195 | |
| TFKVKRKVDRFNGVS | 101 | Q13569 | |
| NILVRSFKDGKFTSV | 211 | Q4LE39 | |
| KDLSFIKVINVGQRF | 211 | O60825 | |
| QVKKAFFALVTNGVR | 56 | P54619 | |
| KIFIAAASEIRGFTK | 81 | Q8IWZ6 | |
| GTRVFVQKEILDKFT | 291 | P49189 | |
| SIITRKEFQEGLKIF | 371 | P06276 | |
| LETIFVRKVGAFVNK | 366 | O75143 | |
| VRVKKGDQTLFSSIF | 276 | Q86XM0 | |
| VRKVAGEKITVTFNI | 121 | Q07021 | |
| LVKEGVSAAFAVKLF | 176 | Q7L1Q6 | |
| KEGKSDRVILFSTQF | 661 | Q8IUA7 | |
| VFSGVARRGKKIFVL | 511 | Q7Z2Z2 | |
| ERKASKVLGIVFFVF | 306 | P28335 | |
| TLQQFLRFGETKSIV | 166 | Q01954 | |
| EKVIVDFAGSSKLRF | 246 | Q7Z2E3 | |
| FLAQSVLAGVKKFDV | 26 | P08572 | |
| SKINLRQGKFEVTIF | 56 | Q3SXY8 | |
| AFVQSIIRKVKSEIG | 766 | O14529 | |
| GRFAKSQSKTFRVAV | 366 | Q16581 | |
| ILKAVKVLQASFRGV | 2166 | Q8IZT6 | |
| VVSSAQEKGRKIAAF | 196 | Q8IUZ5 | |
| AEKTKNFVSRSLVIG | 26 | Q9NUZ1 | |
| EVIGNKTLTQVKTFF | 356 | Q8IZ40 | |
| TVRQGVAQLKDFITK | 531 | O43374 | |
| SRVFIGNLNTAIVKK | 21 | Q86SE5 | |
| KEFHGNIIKVSFATR | 306 | Q92804 | |
| FGTTIKDKSRLFRVQ | 106 | Q7Z4M0 | |
| SKFITTVGIDFREKR | 36 | P51159 | |
| SVIEQLFFVRLVGKT | 376 | P24468 | |
| VKVFGKAVQALSRIS | 11 | Q6WBX8 | |
| RAQGVVLKVLTNFKS | 76 | Q9BPX5 | |
| TLFIRQRKGFVKIAL | 201 | Q96PD6 | |
| VTRVKEFIFLGLTQS | 6 | Q8NGI4 | |
| IQVTDFGFAKRVKGR | 181 | P17612 | |
| FRKVSQRTELVFGLA | 151 | O15481 | |
| RKENEGFGFVILTSK | 856 | Q5TCQ9 | |
| VRVSSNKKLVGFISA | 216 | O60551 | |
| FIRVGQLTKRVDIFS | 386 | O43187 | |
| KVAKAFELIVFSRVV | 126 | Q6PXP3 | |
| TLFGRTIQDVFKSNK | 336 | O60318 | |
| FGKIAKVQRIFTRRS | 456 | O60318 | |
| DTIIRKFEGQSRKFI | 16 | Q12809 | |
| GKDSFKRIFSKEIIV | 221 | Q9Y6W6 | |
| LKTRGIFETKFLSQI | 776 | P52789 | |
| RQRATKKISTFIGTF | 236 | Q8NDV2 | |
| VKTKQIREGVAHRFF | 296 | Q96RD2 | |
| KQSASGTKRRVFIVE | 556 | P17858 | |
| KVTKATAQIGFIKFV | 506 | O76083 | |
| VFTAVSVFLVEKAGR | 351 | P11168 | |
| QKLVVFVFEGTELKL | 1331 | Q6ZR08 | |
| KLVFVDAVAFLTGKR | 291 | P52848 | |
| VIQIQIKDSAKRTFG | 431 | Q5T7B8 | |
| IKDSAKRTFGRISFI | 436 | Q5T7B8 | |
| FQVRKVTGANTGKIF | 106 | P23443 | |
| VALLTGKFSNIVDKF | 421 | P30305 | |
| GVTERFKVSVLVLFA | 76 | P42857 | |
| RSEVFRKSIGILNIF | 711 | Q8NDA8 | |
| SKGNAQRIFVELKFT | 91 | Q15375 | |
| FTKKGFLFRGQISET | 761 | P19367 | |
| LKTRGIFETKFLSQI | 776 | P19367 | |
| KRTFLLVDSVVGIQK | 191 | Q8N3Z3 | |
| VFKKLQAGSIAIVRQ | 231 | Q8NB16 | |
| TGTVEFKEFLVLVFK | 66 | Q9UBG3 | |
| KNVLITDFFGSVRKV | 296 | Q92643 | |
| STFFILAKGKVKVTQ | 321 | Q13237 | |
| LTVATKETEGFRRFK | 31 | Q02809 | |
| EVFLVKQRLTGKLFA | 36 | Q96NX5 | |
| IKGALVKVVAVKFFS | 296 | Q96R84 | |
| SIKGIIRVLNVSFEK | 141 | Q16821 | |
| GRFTAQDTVAIRKVK | 121 | Q96F15 | |
| TIFAFFTKSGRKVLD | 876 | Q13797 | |
| AGFVSLFRIRSVIKQ | 421 | Q13467 | |
| SGNIAIRKSAKVIFA | 86 | A4FU69 | |
| VKEVKIDGQFRVSSF | 1481 | P04114 | |
| TAFKVVRTLKTGFGF | 6 | P31327 | |
| RVTDGGTIKQKIFTF | 61 | Q96ID5 | |
| IQVTDFGFAKRVKGR | 181 | P22694 | |
| NAAVVSAKLKLFVFG | 436 | Q9H0H3 | |
| SSFQGIKKSIFRIRE | 496 | P51587 | |
| QFEGTVEIKRKFAGL | 1181 | P51587 | |
| GALVDKVKSFTKRFI | 56 | P12109 | |
| FVKVRAFLEVLVKSF | 456 | Q99715 | |
| VKKAALVIQQSGFSV | 2441 | Q99715 | |
| IAESVVKKTGFFVNR | 436 | Q92562 | |
| VLKVFLENGQIKSFT | 181 | Q5JV73 | |
| GTNFQKRLFTKIDTI | 131 | P29317 | |
| DIVVQRVGSKLFFDK | 266 | O15371 | |
| TGKALEFVARNLFVK | 1516 | P12111 | |
| VTVFASVIFQTRKDG | 601 | Q9BZC7 | |
| RIFKEAEKFFVSVGL | 306 | Q9BYF1 | |
| VIFILRKKDGQVTFL | 126 | Q9BW60 | |
| IKTFLFISDEKRVVG | 476 | Q56NI9 | |
| TAVVQRIREKFFKGH | 371 | Q9Y4F3 | |
| RFKRISGTSIAFKNI | 771 | Q9P0L2 | |
| EARAVKAFQTFLGKA | 266 | Q9NRM0 | |
| SVRGKDVFIIQTVSK | 66 | O60256 | |
| AGSTKEFFRRSKIAV | 666 | P42261 | |
| REFKKSSVETGFNVI | 101 | Q8IXS0 | |
| DKIKFTVTRPFQGLI | 771 | Q9UHL9 | |
| IIAFRKANKVGIFIK | 391 | Q9UJW0 | |
| TGRSVKIIQADFTKD | 96 | P37058 | |
| RQAGVELKTTSFIFV | 2806 | Q9P225 | |
| KGQFIARFTSQFLKL | 251 | Q5VWM4 | |
| DLFITQGATIKRFVV | 341 | O00237 | |
| RSIKVFDFFGQIKLV | 196 | Q6VVB1 | |
| VKFVKSFINSIRRAI | 2156 | A6NMZ7 | |
| RNFIKTGSTFKVKVG | 3666 | Q8TE73 | |
| LRDFVKTFTAAGIKL | 71 | Q96EK7 | |
| STIEEVFFKKTIGNV | 356 | Q9Y466 | |
| VVKFAGQDFAKLART | 221 | P56373 | |
| TKQIRKSVIKFFQGD | 306 | Q8NH56 | |
| TVVVLRATKVTKGAF | 21 | P47712 | |
| QFRTLKAAVGVSVVI | 131 | Q15743 | |
| VVQAITFIFKSLGLK | 971 | P42345 | |
| TVIVVKKRVNTRFFA | 736 | Q96J94 | |
| GAKVLSSVKDRFINF | 181 | P08581 | |
| RDVKKTGFVFGTTLI | 851 | O95197 | |
| KTALVVRFLTKRFIG | 46 | Q9BPW5 | |
| GSIFENKAKILVIFR | 126 | Q6IMI4 | |
| LNKRRGFVFITFKEE | 191 | Q99729 | |
| DKQIKFTLFKGVITR | 571 | A6NHR9 | |
| RTFASGKTEKVIFQA | 171 | Q15147 | |
| TSIFQLKEVVAKRQG | 21 | O60260 | |
| LKQKGDRVVLFSQFT | 866 | Q9H4L7 | |
| AQFVTTGESARIKAK | 1511 | Q8NF91 | |
| QFTLRIKAAAGVKIT | 311 | Q14DG7 | |
| GSRVKKLKETFAFIQ | 6011 | Q8WXH0 | |
| KFIIVTGQIKADFKR | 41 | Q9H0A3 | |
| ANSEIFRQKVIAKTG | 541 | Q7LBE3 | |
| QERKQIFKGKTFIFL | 216 | O60934 | |
| SGRKLEKFTVSVNVA | 131 | Q06033 | |
| LTSGIFETKFQVDKV | 846 | Q5JWF2 | |
| QKGVDKEFFLLFTVL | 571 | Q9BQS7 | |
| VTEKAGFKRAFIITG | 226 | P30566 | |
| DSTGNVRKLVKVQTF | 366 | Q16819 | |
| KTFIVLNKGKTIFRF | 91 | Q14524 | |
| KTFIVLNKGKTIFRF | 86 | Q15858 | |
| ITNGARKNAFKILVV | 241 | P11215 | |
| FVTNVRSLGVQEKAK | 266 | Q9NUC0 | |
| VKGVQSAAVQAFLKR | 36 | Q68D10 | |
| IVLNKGKAIFRFSAT | 91 | P35498 | |
| RGKILFVSESVFKIL | 166 | O00327 | |
| VDLFNKVVQAGLKTF | 721 | Q86X52 | |
| KVVQAGLKTFRSQEV | 726 | Q86X52 | |
| VGKVFVEKSRRFQAA | 176 | Q96Q45 | |
| RRKKGSFFISQVVLT | 236 | Q63HM9 | |
| KGQFIARFTSQFLKL | 251 | Q5VXH5 | |
| FLRVKFATAAVIVSG | 11 | O95258 | |
| SIVIRIGAKAFNASF | 131 | A0JNW5 | |
| FVFSDKARGKVSEII | 116 | Q86UF1 | |
| RSLFKKETNIQLFVG | 491 | P57772 | |
| KVISELFFTKGNQLR | 786 | Q8IUR5 | |
| RVFFESVVLTNLTGK | 281 | Q7RTX1 | |
| RKKLFITAAIVVIFF | 456 | Q9UBY0 | |
| QLAVTKVFGRFITAI | 531 | Q8NDV3 | |
| KVFGRFITAIVVASE | 536 | Q8NDV3 | |
| TGVQFTTKVRLLVKF | 341 | P40763 | |
| VLTKFNVQKTRFGLT | 316 | Q9P2N2 | |
| GIVQDTLTAVRKFTK | 536 | P24928 | |
| SAIFVGKNVVALATK | 246 | Q9BTD3 | |
| TLKIFIFNQTGIEAK | 286 | Q96J42 | |
| FIVLNKGKAISRFSA | 91 | Q99250 | |
| KQLKERGVTVFAVGV | 171 | Q5GFL6 | |
| TFKSGKFIRIFQLSN | 41 | Q9HBJ7 | |
| SFVKEFKSQLFVEGL | 846 | O43847 | |
| QKTFVVLNRGKTLFR | 91 | Q9UQD0 | |
| LVFFVNGRKVVEKNA | 6 | P47989 | |
| RTFLRAVTKLGFKIV | 401 | O43159 | |
| GVKIFDIISKQRITN | 191 | P49754 | |
| SVILIFSVRESGKFQ | 396 | Q96MU7 | |
| LFKTKFVDGVSTVAR | 1156 | O95347 | |
| QADKSIEVRKFVIGF | 81 | Q92797 | |
| VFIQSRGFKTLKSRT | 201 | Q96TA2 | |
| VRGRKITKNFSEVGF | 836 | Q8N9V7 | |
| LFSVGSLFVKKVQDV | 81 | Q2M3R5 | |
| IIGKFQFTVRTQSDA | 216 | P22735 | |
| RGAEVLTAQFVQKTK | 401 | Q5VWN6 | |
| GAQIVFKEVQKLFKR | 406 | Q8N584 | |
| SVIRQAKAAGKRIVF | 146 | Q5H8A4 | |
| IQIKFVRGSTFKEIP | 651 | Q15063 | |
| FNEVGKLFTQILRVK | 116 | P10301 | |
| IGQTKTVRVFRFITD | 596 | O60264 | |
| QDIIRRFKASKFGST | 306 | P06737 | |
| TFTKIQRKDFAGLTF | 161 | O60603 | |
| FQIIKQARTAVGKDS | 116 | Q6IEG0 | |
| FFAKARAGSVRLIKV | 16 | Q6IBS0 | |
| GKILFRNTTIFLKFD | 56 | Q8NBN3 | |
| TSRLFVKKTIVVGNV | 201 | Q9ULM3 | |
| SIVKEASQRGKVSLF | 141 | Q9GZU3 | |
| LATEVIFKALTGFRN | 81 | O14657 | |
| IQVGKRTIINKLFFD | 51 | Q9BWF2 | |
| SRIKVFANGTLVVKS | 2196 | Q9NR99 |